[3]
Benkeblia N. Ganoderma lucidum polysaccharides and Terpenoids: Profile and health benefits. J Food Nutr Diet 2015; 1: 1-6.
[9]
Bala US, Abdul-Dahiru E-Y, Fanna IA, Adamu OO, Sandabe UK. In vitro inhibition of neuraminidase activity of influenza virus (H5N2) by methanolic soluble fraction of Ganoderma lucidum extract. Int J Modern Biol Med 2013; 4(3): 147-54.
[15]
Chinsembu KC. Phytomedicines and nutraceuticals in the clinical management of COVID-19. Int Sci 2021; 14(1): 1-8.
[33]
Bhat JA, Wani AH, War JM, Bhat MY. Major bioactive properties of ganoderma polysaccharides: A review. Asian J Pharm Clin Res 2021; 14(3): 11-24.
[48]
Kolivand M, Keramat A, Khosravi A. The effect of herbal teas on management of polycystic ovary syndrome: A systematic review. J Midwifery Reprod Health 2017; 5(4): 1098-106.
[50]
Gupte A, Palande A, Venkata S, Pol R. Docking studies of Ganoderma lucidum. Int J Pharm Sci Res 2018; 9(3): 1100-5.
[56]
AL-jumaili MMO. Al-dulaimi FKY, Ajeel MA. The role of Ganoderma lucidum uptake on some hematological and immunological response in patients with Coronavirus (COVID-19). Syst Rev Pharm 2020; 11(8): 537-41.
[58]
Florez-Sampedro L, Zapata W, Orozco LP. In vitro anti-hiv-1 activity of the enzymatic extract enriched with laccase produced by the fungi ganoderma sp. and lentinus sp. Vitae 2016; 23(2): 109-18.
[67]
Kumar SP, Girija AS, Priyadharsini JV. Targeting NM23-H1-mediated inhibition of tumour metastasis in viral hepatitis with bioactive compounds from Ganoderma lucidum: A computational study. Indian J Pharm Sci 2020; 82(2): 300-5.
[68]
Garba KYAM, Manjong FT, Tiagueu Yvette T. Potentials of nutritional therapy, phytopharmaceuticals and phytomedicine in the prevention and control of Ebola virus in Africa. Am J Clin Exp Med 2015; 3(1): 1-6.
[69]
Wachtel-Galor S, Yuen J, Buswell JA, Benzie IF. Ganoderma lucidum (Lingzhi or Reishi)Herbal medicine: Biomolecular and clinical aspects. (2nd ed.), Florida: CRC Press/Taylor & Francis 2011.
[71]
Pattanayak S, Das S, Biswal G. Ganoderma: The wild mushroom with wonderful health benefits. J Pharmacogn Phytochem 2020; 9(2)
[80]
Mishra J, Misra K. Exploring indian traditional medicinal sources as prophylactic strategy against COVID-19. Int J Environ Health Sci 2020; 2(1): 115-23.
[84]
Eo S-K, Kim YS, Lee CK, Han SS. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol 2002; 32(3): 475-81.
[85]
Hijikata Y, Yamada S, Yasuhara A. Herbal mixtures containing the mushroom Ganoderma lucidum improve recovery time in patients with herpes genitalis and labialis. J Altern Complement Med 2007; 13(9): 985-7.
[91]
Li Y, Yang Y, Fang L, Zhang Z, Jin J. Anti-hepatitis activities in the broth of Ganoderma lucidum supplemented with a Chinese herbal medicine. Am J Chin Med 2006; 34(2): 341-9.
[92]
Hernandez-Marquez E, Lagunas-Martinez A, Bermudez-Morales VH, Burgete-Garcfa AI, Leon-Rivera I, Montiel-Arcos E, et al. Inhibitory activity of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (Higher Basidiomycetes) on transformed cells by Human Papillomavirus. Int J Med Mushrooms 2014; 16(2): 179-87.
[93]
Cheng PG, Teoh TC, Rizman-Idid M. Chemical compounds and computational prediction of their inhibitory effects on the HIV-1 gp120 receptor by Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes), with antler-like morphology of fruiting bodies. Int J Med Mushrooms 2021; 23(7): 63-77.
[95]
Shah M, Woo YG. Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies. Front Immunol 2022; 12: 830527.
[96]
Omotuyi O, Olubiyi O, Nash O, et al. SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody. Comput Biol Med 2022; 142: 105226.